🔎 Trials Near Me

Akèy › Limfòm selil B › Missouri › St. Louis

Etid klinik pou Limfòm selil B nan St. Louis, MO

5 etid pou Limfòm selil B ap chèche patisipan nan sit nan ak bò kote St. Louis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

Ap rekriteFaz 3
  • Washington University School of Medicine, St Louis
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06742996

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

Ap rekriteFaz 1/2
  • Washington University School of Medicine, St Louis
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06634589

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

Ap rekriteFaz 1
  • Washington University School of Medicine/Siteman Cancer Center, St Louis
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT06528301

DALY II USA/ MB-CART2019.1 for DLBCL

Ap rekriteFaz 2
  • Washington University, St. Louis, St Louis
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT04792489

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

Ap rekriteFaz 1/2
  • Washington University, St Louis
Laj 18 ak plis · Tout sèks · Mizajou Nov 14, 2025 · NCT05643742

Etid Limfòm selil B nan lòt vil

Lòt etid nan St. Louis

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.